ArticleNeoplasia (New York, N.Y.)2015

Doxil synergizes with cancer immunotherapies to enhance antitumor responses in syngeneic mouse models.

Jonathan Rios-Doria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.